Clinical Trial Update: Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Antipsychotic Drugs in Healthy Humans [NA]

View source ↗

Summary

Update on a completed clinical trial examining how subchronic dopamine D2 receptor blockade by antipsychotic drugs affects metabolic parameters in healthy human…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Insulin Resistance

Snippet

Sponsor: Leiden University Medical Center | Conditions: Insulin Resistance, Dyslipidemia | NA | Status: COMPLETED